Related Experiment Video
Updated: Apr 23, 2026

Synovial Fluid Analysis to Identify Osteoarthritis
Published on: October 20, 2022
Ocular manifestations of seronegative spondyloarthropathies
Sophia L Zagora1, Peter McCluskey
1aSave Sight Institute, Discipline of Ophthalmology, Sydney Medical School, University of Sydney bSydney Eye Hospital, Sydney, Australia.
Purpose Of Review:
This article reviews recent advances in the understanding of the ocular manifestations of seronegative spondyloarthropathies.
Recent Findings:
Ocular inflammatory disorders are common and important disease manifestations in patients with seronegative spondyloarthropathy, with anterior uveitis being the most common. There is a strong association between affected patients and the human leukocyte antigen B27. Local corticosteroid treatment is usually effective, but chronic or refractory uveitis responds well to immunosuppressive drugs that are effective for arthritis. Recent studies have highlighted the possible benefits of a number of biologic agents, including tumor necrosis factor-alpha inhibitors in such patients.
Summary:
Uveitis is the most common ocular manifestation in patients affected by seronegative spondyloarthropathies. Both genetic and environmental factors play a role in its pathogenesis. As it tends to affect the young adult population, it carries a significant personal and population burden. Immunomodulatory therapy that also acts as a corticosteroid sparing therapy can be effective in controlling chronic uveitis in patients with spondyloarthropathy.
More Related Videos
Related Concept Videos
Endocarditis II: Clinical Features of Infective Endocarditis
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Nephrotic Syndrome I : Introduction
Chronic Kidney Disease II: Clinical Manifestations
Graves' Disease I: Introduction
Multiple Sclerosis l: Introduction

